Structure-activity relationships of histamine H2 receptor ligands

被引:31
作者
Dove, S
Elz, S
Seifert, R
Buschauer, A [1 ]
机构
[1] Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany
[2] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA
关键词
H-2 receptor agonists; H-2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; QSAR; site-directed mutagenesis;
D O I
10.2174/1389557043403242
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recent research on histamine H-2 receptor agonists was focused on quantitative structure-activity relationships and receptor models explaining the activity of imidazolylpropylguanidines. Their selectivity for guinea pig vs. human isoforms was investigated using H-2 receptor-G(salpha) fusion proteins and attributed to amino acid differences in transmembrane domains 1 and 7. New antagonists result from approaches to improve pharmacokinetic properties and to design hybrid drugs which additionally have gastroprotective or anti H. pylori activity.
引用
收藏
页码:941 / 954
页数:14
相关论文
共 162 条
[41]   (IMIDAZOLYLPHENYL)FORMAMIDINES - A STRUCTURALLY NOVEL CLASS OF POTENT HISTAMINE H-2-RECEPTOR ANTAGONISTS [J].
DONETTI, A ;
CEREDA, E ;
BELLORA, E ;
GALLAZZI, A ;
BAZZANO, C ;
VANONI, P ;
DELSOLDATO, P ;
MICHELETTI, R ;
PAGANI, F ;
GIACHETTI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) :380-386
[42]   Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide YY1 receptor antagonists [J].
Dove, S ;
Michel, MC ;
Knieps, S ;
Buschauer, A .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 78 (02) :108-115
[43]  
Dove S, 1999, QUANT STRUCT-ACT REL, V18, P329, DOI 10.1002/(SICI)1521-3838(199910)18:4<329::AID-QSAR329>3.0.CO
[44]  
2-V
[45]  
Dove S, 1998, Pharm Acta Helv, V73, P145, DOI 10.1016/S0031-6865(98)00015-6
[46]   IMPROMIDINE (SK AND F 92676) IS A VERY POTENT AND SPECIFIC AGONIST FOR HISTAMINE H-2 RECEPTORS [J].
DURANT, GJ ;
DUNCAN, WAM ;
GANELLIN, CR ;
PARSONS, ME ;
BLAKEMORE, RC ;
RASMUSSEN, AC .
NATURE, 1978, 276 (5686) :403-405
[47]   POTENTIAL HISTAMINE H2-RECEPTOR ANTAGONISTS .3. METHYLHISTAMINES [J].
DURANT, GJ ;
EMMETT, JC ;
GANELLIN, CR ;
ROE, AM ;
SLATER, RA .
JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (07) :923-928
[48]   CHEMICAL DIFFERENTIATION OF HISTAMINE H1-RECEPTOR AND H2-RECEPTOR AGONISTS [J].
DURANT, GJ ;
GANELLIN, CR ;
PARSONS, ME .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (09) :905-909
[49]  
ELZ S, 1988, ARZNEIMITTELFORSCH, V38-1, P327
[50]   SYNTHESIS AND H-2-AGONISTIC ACTIVITY OF ALKYL-3-(IMIDAZOLE-4-YL)PROPYLGUANIDINES [J].
ELZ, S ;
SCHUNACK, W .
ARCHIV DER PHARMAZIE, 1987, 320 (02) :182-185